Adiponectin inhibits lymphotoxin-β receptor-mediated NF-κB signaling in human umbilical vein endothelial cells

被引:14
作者
Xu, Yizhou [1 ,2 ,3 ,4 ]
Zhang, Chu [1 ,2 ]
Wang, Ningfu [1 ,2 ]
Ling, Feng [1 ,2 ]
Li, Peizhang [1 ,2 ]
Gao, Yan [1 ,2 ]
Hua, Wei [3 ,4 ]
机构
[1] Nanjing Med Univ, Dept Cardiol, Hangzhou Peoples Hosp 1, Hangzhou 310006, Zhejiang, Peoples R China
[2] Nanjing Med Univ, Hangzhou Hosp, Hangzhou 310006, Zhejiang, Peoples R China
[3] Chinese Acad Med Sci, Fu Wai Hosp, Cardiac Arrhythmia Ctr, Cardiovasc Inst, Beijing 100037, Peoples R China
[4] Peking Union Med Coll, Beijing 100037, Peoples R China
关键词
Adiponectin; AdipoR1; LTBR; Yeast two-hybrid screen; NF-kappa B; GLOBULAR ADIPONECTIN; CARDIOVASCULAR-DISEASE; TRANSCRIPTION FACTOR; DEFICIENT MICE; ATHEROSCLEROSIS; PROLIFERATION; ACTIVATION; EXPRESSION;
D O I
10.1016/j.bbrc.2010.12.110
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adiponectin exerts anti-diabetic and anti-atherogenesis properties through its 2 receptors (AdipoR1 and AdipoR2). However, the signaling pathways responsible for the anti-inflammatory effects of adiponectin are largely unknown. In this study, we identified the lymphotoxin (LT)-beta receptor (LTBR) as an interacting partner of human AdipoR1 by using a yeast two-hybrid screening. The interaction between LTBR and AdipoR1 was confirmed by co-immunoprecipitation and co-localization analysis. Furthermore, adiponectin incubation inhibited lymphotoxin-induced NF-kappa B activation and the expression of adhesion molecules in human umbilical vein endothelial cells. These results indicated that AdipoR1 interacted with LTBR and mediated the inhibition of LTBR-activated NF-kappa B pathway. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:1060 / 1064
页数:5
相关论文
共 26 条
[1]   Adiponectin: from obesity to cardiovascular disease [J].
Antoniades, C. ;
Antonopoulos, A. S. ;
Tousoulis, D. ;
Stefanadis, C. .
OBESITY REVIEWS, 2009, 10 (03) :269-279
[2]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[3]   ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism [J].
Berg, AH ;
Combs, TP ;
Scherer, PE .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02) :84-89
[4]   LYMPHOTOXIN-BETA, A NOVEL MEMBER OF THE TNF FAMILY THAT FORMS A HETEROMERIC COMPLEX WITH LYMPHOTOXIN ON THE CELL-SURFACE [J].
BROWNING, JL ;
NGAMEK, A ;
LAWTON, P ;
DEMARINIS, J ;
TIZARD, R ;
CHOW, EPC ;
HESSION, C ;
OBRINEGRECO, B ;
FOLEY, SF ;
WARE, CF .
CELL, 1993, 72 (06) :847-856
[5]   T lymphocyte-endothelial cell interactions [J].
Choi, J ;
Enis, DR ;
Koh, KP ;
Shiao, SL ;
Pober, JS .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :683-709
[6]   TRANSCRIPTIONAL REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES - NF-KAPPA-B AND CYTOKINE-INDUCIBLE ENHANCERS [J].
COLLINS, T ;
READ, MA ;
NEISH, AS ;
WHITLEY, MZ ;
THANOS, D ;
MANIATIS, T .
FASEB JOURNAL, 1995, 9 (10) :899-909
[7]  
de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83
[8]   Adipokines and vascular disease in diabetes [J].
Goldstein B.J. ;
Scalia R. .
Current Diabetes Reports, 2007, 7 (1) :25-33
[9]   Protective vascular and myocardial effects of adiponectin [J].
Goldstein, Barry J. ;
Scalia, Rosario G. ;
Ma, Xin L. .
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2009, 6 (01) :27-35
[10]   Adiponectin: A novel adipokine linking adipocytes and vascular function [J].
Goldstein, BJ ;
Scalia, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2563-2568